Materion Corp. (MTRN) Tops Q1 EPS by 15c, Offers Guidance

Materion Corp. (NYSE: MTRN) reported Q1 EPS of $1.20, $0.15 better than the analyst estimate of $1.05. Revenue for the quarter came in at $449 million versus the consensus estimate of $415.03 million.

• adjusted EPS with acquisition amortization of $1.08, up 32% versus prior year

GUIDANCE:

Materion Corp. sees FY2022 EPS of $5.50-$5.90, versus the consensus of $5.00.

For earnings history and earnings-related data on Materion Corp. (MTRN) click here.

You May Also Be Interested In

• Wolfe Research upgrades Biogen, AbbVie on pipeline strength and valuation
• Karyopharm Therapeutics (KPTI) Misses Q2 EPS by $1.01, Beats on Revenue; Offers FY26 Revenue Guidance
• CorMedix (CRMD) Tops Q2 EPS by 6c; Offers Guidance